Drug Discovery and Development in the Age of Molecular Medicine

Drug discovery might be better termed drug invention. Discoveries take place globally, and many arise from academia and research institutes. The job of the biotechnology and pharmaceutical industry is to identify those that stand the greatest chance of being turned into medicines to improve health—in other words, to invent a practical outcome on the basis of discovery. In this commentary we identify some of the areas in which molecular medicine has had the greatest impact and continues to change the invention of medicines.

[1]  R B Altman,et al.  The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug Response , 2007, Clinical pharmacology and therapeutics.

[2]  R. Jove,et al.  Expression and role of Foxa proteins in prostate cancer , 2006, The Prostate.

[3]  Z. Hall.  Cancer , 1906, The Hospital.

[4]  James J. Wolff,et al.  Pharmacogenetics and irinotecan therapy. , 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[5]  F. Montemurro,et al.  Lapatinib: a dual inhibitor of EGFR and HER2 tyrosine kinase activity , 2007, Expert opinion on biological therapy.

[6]  L. Lesko,et al.  Paving the Critical Path: How can Clinical Pharmacology Help Achieve the Vision? , 2007, Clinical pharmacology and therapeutics.

[7]  Francis S Collins,et al.  Realizing the promise of genomics in biomedical research. , 2005, JAMA.

[8]  T. Hudson,et al.  Influence of human genome polymorphism on gene expression. , 2006, Human molecular genetics.

[9]  D. M. Grant,et al.  The Art and Science of Personalized Medicine , 2007, Clinical pharmacology and therapeutics.

[10]  J. Reidhaar-Olson,et al.  Genetic association meets RNA interference: large-scale genomic screens for causation and mechanism of complex diseases. , 2007, Pharmacogenomics.

[11]  S. Ekker,et al.  Functional Analysis of Human Hematopoietic Stem Cell Gene Expression Using Zebrafish , 2005, PLoS biology.